Neuromod Scientific Advisory Board
Neuromod collaborates with opinion-leading scientists and clinicians to advance the science of bimodal neuromodulation.
Leading Tinnitus Expertise
Neuromod’s bimodal neuromodulation device, Lenire®, has been subject to three large-scale clinical trials with 600+ participants. Neuromod’s clinical trial design is advised by a Scientific Advisory Board consisting of the world’s foremost tinnitus key opinion leading scientists, authors and experts.
Scientific Advisory Board Members
Prof. Berthold Langguth
Prof. Berthold Langguth is a Consultant Neuropsychiatrist who runs the Department of Psychiatry and Psychosomatic Medicine at Germany’s University of Regensburg Hospital. University of Regensburg Hospital is a leading European site for clinical trials and tinnitus research.
Prof. Langguth is an international key opinion leader in the field of tinnitus research. He has over 300 peer-reviewed publications and book chapters. A key focus area of research is patient subtyping and neuromodulation.
Prof. Langguth founded the Tinnitus Research Initiative (TRI). TRI is a non-profit organisation comprised of tinnitus scientists from across the globe. TRI is dedicated to developing effective tinnitus treatments.
Prof. Sven Vanneste
Prof. Sven Vanneste is Professor of Neurosciences at Trinity College Dublin (TCD) in Ireland and the University of Texas at Dallas in the USA.
Prof. Vanneste is Chair of Clinical Neuroscience and Head of the School of Psychology at TCD.
A leading voice in the field of neuromodulation research, with over 250 peer-reviewed publications and book chapters.
Prof. Vanneste has established a neuromodulation research laboratory that has become a leading neuromodulation research centre globally.
He has collaborated on invasive and non-invasive neuromodulation trials for the Enterprise Ireland, the Health Research, Board, US Department of Defence (US-DoD), the US National Institutes for Health (NIH) and the US Food and Drug Administration (FDA) for neuromodulation start-ups and large medical device multinationals.
Prof. Deborah Hall
Prof. Deborah Hall is currently Head of the Department of Psychology at Heriot-Watt University Malaysia. She holds an appointment as Professor of Positive Psychology.
Prior to this, Prof. Hall led active tinnitus and translational neuroscience research teams at the University of Nottingham, UK. She was Deputy Director of the National Institute for Health Research Nottingham Biomedical Research Centre.
In the fields of clinical trial methodologies and evidence-based medicines, Prof. Hall is highly regarde. She has over 100 peer-reviewed publications and book chapters.
She earned the British Society of Audiology Thomas Simm Littler Prize in 2010 for her services to audiology. Prof. Hall is the Editor of ‘Hearing Research’, one of the highest impact factor journals in auditory research.
Lenire Clinical Trials
80% of Lenire’s first clinical trial patients had a reduction in tinnitus severity that sustained for at least 12 months after treatment. 1
91% of Lenire’s second clinical trial patients had a reduction in tinnitus severity that sustained for at least 12 months after treatment. 2
Majority of patients with moderate or worse tinnitus had significant relief using Lenire when sound-only, the trial’s control, had no meaningful impact.3
